Zimbabwe has rejected a substantial American healthcare agreement valued at 367 million US dollars (£272m) over five years due to Washington's insistence on sensitive data.
This rejection was revealed following a official document dated December was disclosed, revealing that President Emmerson Mnangagwa believed the deal was "lopsided".
An official representative has since clarified that the US was seeking health data for scientific study and commercial gain while was unwilling to share the benefits from future treatments.
"We will now turn to the difficult and regrettable process of winding down our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had donated more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for further negotiations to reach a deal suitable to both sides so the country's vital HIV treatment initiative can be sustained.
Wider Context
Zimbabwe's decision comes after a comparable case in Kenya, where a court suspended a similar health funding agreement following legal challenges were filed about the safety of citizens' health data.
Since resuming office recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
The agency had overseen aid for the US government, but Trump argued its spending was "inefficient" and his administration was pursuing government-to-government agreements to enhance openness and accountability.
According to reports, 16 African countries have so far signed similar health pacts, representing over $18.3bn in new funding.
Details of the Rejected Deal
The funds for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership might have yielded immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently on antiretroviral therapy through US-supported initiatives," Tremont commented.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, with no corresponding promise of benefiting from any medical innovations – like new medicines or tests – that could be developed from that provided information," he stated.
"Put simply, our country would supply the raw materials for medical research with no certainty that the resulting innovations would be accessible to our citizens should a new pandemic arise."
National Interest and International Frameworks
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending systems previously set up via the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to deal with future pandemics.
"This framework is designed to ensure that when a nation contributes its samples, the benefits – such as medicines and cures – are shared equitably, not monopolised solely by those with the resources to create them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We welcome further dialogue with our American counterparts on how future co-operation could be arranged in a manner that respects the sovereignty and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but suggested that talks should continue considering much of the country's HIV programmes were funded by international support.
"If specific concerns exist, including those relating to data governance or implementation frameworks, these can often be resolved via technical clarification and mutually agreed protections," the group commented.
The situation emphasises the complex tensions between receiving much-needed foreign assistance and safeguarding local interests in an increasingly interconnected world.